Znanstveni rad - Izvorni znanstveni rad
Immune-mediated platelet transfusion refractoriness in a severely thrombocytopenic patient with myelodysplastic syndrome successfully treated with romiplostim
Transfusion and Apheresis Science, (2022); 103582. https://doi.org/10.1016/j.transci.2022.103582

Krečak, Ivan; Skorić, Ivana; Čengić, Marina; Krečak, Filip; Skelin, Marko

Citirajte ovaj rad

Krečak, I., Skorić, I., Čengić, M., Krečak, F. i Skelin, M. (2022). Immune-mediated platelet transfusion refractoriness in a severely thrombocytopenic patient with myelodysplastic syndrome successfully treated with romiplostim. Transfusion and Apheresis Science. doi: 10.1016/j.transci.2022.103582

Krečak, Ivan, et al. "Immune-mediated platelet transfusion refractoriness in a severely thrombocytopenic patient with myelodysplastic syndrome successfully treated with romiplostim." Transfusion and Apheresis Science, 2022. https://doi.org/10.1016/j.transci.2022.103582

Krečak, Ivan, Ivana Skorić, Marina Čengić, Filip Krečak i Marko Skelin. "Immune-mediated platelet transfusion refractoriness in a severely thrombocytopenic patient with myelodysplastic syndrome successfully treated with romiplostim." Transfusion and Apheresis Science (2022). https://doi.org/10.1016/j.transci.2022.103582

Krečak, I., et al. (2022) 'Immune-mediated platelet transfusion refractoriness in a severely thrombocytopenic patient with myelodysplastic syndrome successfully treated with romiplostim', Transfusion and Apheresis Science. doi: 10.1016/j.transci.2022.103582

Krečak I, Skorić I, Čengić M, Krečak F, Skelin M. Immune-mediated platelet transfusion refractoriness in a severely thrombocytopenic patient with myelodysplastic syndrome successfully treated with romiplostim. Transfusion and Apheresis Science [Internet]. 10.2022. [pristupljeno 13.07.2024.]. doi: 10.1016/j.transci.2022.103582

I. Krečak, I. Skorić, M. Čengić, F. Krečak i M. Skelin, "Immune-mediated platelet transfusion refractoriness in a severely thrombocytopenic patient with myelodysplastic syndrome successfully treated with romiplostim", Transfusion and Apheresis Science, Listopad 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:541304. [Citirano: 13.07.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.